MENU
RGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
REGENXBIO (RGNX) Ownership - Who owns REGENXBIO?
Regenxbio Inc is a biotechnology company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
455.13M
P/E Ratio
N/A
Total Cash
323.3M
Projected Growth
N/A
Total Debt
77.7M
Revenue
155.78M
Risk (Beta)
1.51
Dividend Yield
N/A
Total Cash/Share
6.40
Total Debt/Equity
N/A
Revenue/Share
3.05 USD as % of share price
Fundamentals
RGNX
Capitalization
455M
P/E Ratio
N/A
Risk (Beta)
1.51
Dividend Yield
N/A
Total Cash
323M
Total Cash/Share
6.40
Total Debt
77.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.05%
Revenue
156M
ROE
N/A
Book Value
214M
P/B Ratio
2.13
Cash Flow
N/A
Earnings
-3.44
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.13
Current Revenue Per Employee
60507.08
Dividends Per Share - Security
N/A
EBITDA
-129.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
75.61
Revenue To Assets
-30.52
Shares Held By Institutions
458M
Shares Outstanding - Current
50.5M
Total Liabilities
367M
Total Volume MTD
N/A
Value
-1
Gain YTD
16.559
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RGNX showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of gene therapy treatments
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com